Related Experiment Video
Updated: Jan 29, 2026

Assessing the Coherence of Parents' Short Narratives Regarding their Child Using the Five-Minute Speech Sample Procedure
Published on: September 19, 2019
Evaluation and management of the child with hypothyroidism
Alexander K C Leung1, Alexander A C Leung2
1Department of Pediatrics, The University of Calgary, and The Alberta Children's Hospital, #200, 233 - 16th Avenue NW, Calgary, AB, T2M 0H5, Canada. aleung@ucalgary.ca.
Insights
Early diagnosis and treatment of hypothyroidism are crucial for optimal neurocognitive and physical development in children. Prompt intervention with levothyroxine, especially in infants, improves outcomes and prevents long-term complications.
Area of Science:
- Pediatric Endocrinology
- Developmental Neuroscience
Background:
- Thyroid hormones are essential for normal childhood growth and neurocognitive development.
- Timely identification and management of hypothyroidism are critical for optimizing patient outcomes.
Purpose of the Study:
- To review the importance of prompt diagnosis and treatment of hypothyroidism in children.
- To highlight key aspects of congenital and acquired hypothyroidism management.
Main Methods:
- A literature search was conducted using PubMed with the keyword "hypothyroidism".
Main Results:
- Congenital hypothyroidism stems from thyroid dysgenesis (85%) or dyshormonogenesis (15%).
- Newborn screening detects congenital hypothyroidism, often asymptomatic in infants.
- Hashimoto thyroiditis and iodine deficiency are leading causes of acquired hypothyroidism globally.
- Central hypothyroidism is rare and may link to other hormonal deficiencies.
Conclusions:
- Initiate levothyroxine treatment within the first two weeks of life for congenital hypothyroidism to enhance neurocognitive outcomes.
- Early treatment of acquired hypothyroidism is vital for normal growth, development, and cognitive function.
- Therapeutic goals include maintaining serum TSH < 5 mIU/L and T4 levels in the upper half of the reference range, alongside symptom resolution.
Background:
Thyroid hormones are critical for early neurocognitive development as well as growth and development throughout childhood. Prompt recognition and treatment of hypothyroidism is, therefore, of utmost importance to optimize physical and neurodevelopmental outcomes.
Data Sources:
A PubMed search was completed in Clinical Queries using the key terms "hypothyroidism".
Results:
Hypothyroidism may be present at birth (congenital hypothyroidism) or develop later in life (acquired hypothyroidism). Thyroid dysgenesis and dyshormonogenesis account for approximately 85% and 15% of permanent cases of congenital primary hypothyroidism, respectively. More than 95% of infants with congenital hypothyroidism have few, if any, clinical manifestations of hypothyroidism. Newborn screening programs allow early detection of congenital hypothyroidism. In developed countries, Hashimoto thyroiditis is the most common cause of goiter and acquired hypothyroidism in children and adolescents. Globally, iodine deficiency associated with goiter is the most common cause of hypothyroidism. Central hypothyroidism is uncommon and may be associated with other congenital syndromes and deficiencies of other pituitary hormones. Familiarity of the clinical features would allow prompt diagnosis and institution of treatment.
Conclusions:
To optimize neurocognitive outcome in infants with congenital hypothyroidism, treatment with levothyroxine should be started as soon as possible, preferably within the first 2 weeks of life. Children with acquired hypothyroidism should also be treated early to ensure normal growth and development as well as cognitive outcome. The target is to keep serum TSH < 5 mIU/L and to maintain serum free T4 or total T4 within the upper half of the age-specific reference range, with elimination of all symptoms and signs of hypothyroidism.
Related Concept Videos
Tonsillitis II: Management
Impression Management Techniques I: Managing Appearances
Managing Impressions
Management of Insomnia
Cystic Fibrosis: Management
Sinus disease and chronic...
Angina IV: Management

